Findings of a Mendelian randomization analysis showed that greater body mass index as a child and adult and incidence of smoking were associated with an increased risk of psoriasis, whereas having more education was cited as a potential protective factor against development.
Smoking cessation and prevention of obesity may decrease the risk of psoriasis development, according to findings published in Journal of the American Academy of Dermatology.
Psoriasis is a known contributor to psychosocial disability and impaired quality of life, with patients exhibiting a 21% greater risk of mortality than the general population. Although it is essential to understand the factors that causally affect risk, researchers noted that evidence for causal relationships between modifiable factors and psoriasis mostly comes from conventional observational studies.
“A limitation of observational studies is that the causality of the associations cannot be inferred, as results may be biased by confounding and reverse causation,” they explained.
Mendelian randomization (MR) is an analytic approach in which genetic variants are used as proxies, or instrumental variables, for putative risk factors. As these genetic variants are randomly assorted at conception, the researchers said, “They are not influenced by reverse causation, and in the absence of pleiotropic associations (associations between genetic variants and disease through alternative pathways), they can provide unconfounded estimates of disease risk.”
A 2-sample MR analysis was conducted to investigate the causality between the risk of psoriasis and several potentially modifiable factors: smoking behavior (initiation and lifetime index), alcohol and coffee consumption, sleep duration, physical activity, education, overall obesity (childhood and adult body mass index [BMI]) and abdominal obesity (waist-to-hip ratio, waist circumference), and hip circumference.
For each modifiable risk factor, effect estimates for each single-nucleotide polymorphism (SNP) used as instruments in the MR analysis were retrieved from several large-scale genome-wide association studies (GWAS). The number of SNPs used as genetic instruments for the examined modifiable factors ranged from 4 to 505, in which the primary method used for assessment was the random-effects inverse variance weighted (IVW).
Findings of the univariate 2-sample MR analysis showed an increased risk of psoriasis for each standard deviation [SD] increase of genetically predicted lifetime smoking index (ORIVW, 2.11; 95% CI, 1.28-3.51), childhood (ORIVW, 1.40; 95% CI, 1.14-1.71) and adult BMI (ORIVW, 1.63; 95% CI, 1.32-2), waist circumference (ORIVW, 1.86; 95% CI, 1.31-2.64), and hip circumference (ORIVW, 1.55; 95% CI, 1.15-2.07).
A protective association was additionally reported between genetically predicted longer sleep duration (ORIVW, 0.56; 95% CI, 0.37-0.84) and increased years of education (ORIVW, 0.78; 95% CI, 0.62-0.98). Moreover, the protective effect of education was found to persist in multivariable MR (MVMR) after adjusting for genetic predictors of lifetime smoking index and adult BMI (ORMVMR-IVW, 0.72; 95% CI, 0.56-0.92). For childhood BMI, the direct effect (not mediated by adult BMI) was null (ORMVMR-IVW, 1.01; 95% CI, 0.79-1.29; P = .96).
The researchers noted that as all analyses were performed using summary-level data derived from the GWAS on Europeans, their findings may not be generalizabile to non-European populations. The inability to explore the causal effect of the examined factors on the severity of psoriasis or various disease subtypes was also noted as a potential limitation.
“Continuation of existing or introduction of new approaches to tackle obesity and smoking are of great importance not only to reduce the incidence of psoriasis but of several diseases as well,” concluded the researchers. “Higher levels of education are also crucial for psoriasis prevention, further enhancing the lengthy list of conditions associated with educational levels and further highlighting the lifelong benefits of education on good health.”
Reference
Chalitsios CV, Georgiou A, Bouras E, et al. Investigating modifiable pathways in psoriasis: A Mendelian randomization study. J Am Acad Dermatol. Published online November 9, 2022. doi:10.1016/j.jaad.2022.11.010
Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available
November 30th 2023Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
November 29th 2023Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Read More